2022
Exports
$16.1MWorld Rnk 66 / 208
Flag Rnk 585 / 1176
2022
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.38Rnk 75 / 1025
2022
Imports
$1.16BWorld Rnk 34 / 225
Flag Rnk 53 / 1208
2022
ECONOMIC COMPLEXITY of Vietnam
0.2Rnk 55 / 133

About

Exports In 2022, Vietnam exported $16.1M in Vaccines, blood, antisera, toxins and cultures, making it the 66th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 585th most exported product in Vietnam. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Vietnam are: Japan ($6.28M), Laos ($2.15M), Cambodia ($2.07M), India ($1.09M), and Pakistan ($1.07M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Vietnam between 2021 and 2022 were Laos ($1.91M), Japan ($1.27M), and India ($470k).

Imports In 2022, Vietnam imported $1.16B in Vaccines, blood, antisera, toxins and cultures, becoming the 34th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 53rd most imported product in Vietnam. Vietnam imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($217M), United States ($201M), Germany ($191M), South Korea ($117M), and France ($90.5M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Vietnam between 2021 and 2022 were Australia ($19.3M), Ireland ($17.2M), and France ($14.6M).

Latest Trends

Jul 2024

Subnational Monthly Trade

View
Flow
Y-AXIS SCALE

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

The following visualization shows the latest trends on Vaccines, blood, antisera, toxins and cultures. Countries are shown based on data availability.

* Using January 2020 exchange rates when trade data is reported in local currency.

Explore Latest Trends

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$16.1M
IMPORTS (2022)$1.16B
NET TRADE (2022)-$1.15B

In 2022, Vietnam exported $16.1M in Vaccines, blood, antisera, toxins and cultures. The main destinations of Vietnam exports on Vaccines, blood, antisera, toxins and cultures were Japan ($6.28M), Laos ($2.15M), Cambodia ($2.07M), India ($1.09M), and Pakistan ($1.07M).

In 2022, Vietnam imported $1.16B in Vaccines, blood, antisera, toxins and cultures, mainly from Belgium ($217M), United States ($201M), Germany ($191M), South Korea ($117M), and France ($90.5M).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Vietnam WERE (2021 - 2022):
Laos$1.91M (795%)
Japan$1.27M (25.3%)
India$470k (76.3%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Vietnam WERE (2021 - 2022):
Ukraine-$228k (-100%)
Czechia-$213k (-100%)
United States-$111k (-70.1%)

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, Vietnam's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2022, Vietnam's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALJapan+ $6.2M
TOP IMPORT POTENTIALUnited States+ $68.4M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is Japan. With an export gap of $6.2M.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is United States with an import gap of $68.4M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with